G Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Genpact Ltd is not a strong buy for a beginner investor with a long-term strategy at this time. While the company has shown solid financial performance and momentum in its Advanced Technology Solutions segment, the lack of positive trading signals, hedge fund selling, and a bearish short-term stock trend make it prudent to hold off on investing immediately.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral, and moving averages are converging, showing no clear trend. The stock is trading near a resistance level (R1: 41.224), which could limit immediate upside potential. Additionally, similar candlestick patterns suggest a high probability of short-term declines (-0.83% next day, -3.28% next week, -11.01% next month).
The company delivered solid Q4 results, with revenue, net income, EPS, and gross margin all showing year-over-year growth. The Advanced Technology Solutions segment continues to drive momentum.
Hedge funds are aggressively selling, with a significant 805.73% increase in selling activity last quarter. Analysts have lowered price targets, and the stock shows a bearish short-term trend. No recent news or congress trading data to provide additional positive sentiment.
In Q4 2025, Genpact's revenue increased by 5.65% YoY to $1.32 billion, net income rose by 0.83% YoY to $143.09 million, EPS grew by 3.80% YoY to $0.82, and gross margin improved by 2.33% YoY to 36%.
Analysts are mixed: Needham maintains a Buy rating with a reduced price target of $50, while Susquehanna has a Neutral rating with a lowered price target of $42. Analysts acknowledge solid execution and momentum in ATS but express concerns about slower growth in the core business.
